Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Local Stocks
San Gabriel Valley Index
San Gabriel Valley
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Windtree Therapeutics Inc
(NQ:
WINT
)
3.190
-4.920 (-60.67%)
Streaming Delayed Price
Updated: 4:00 PM EDT, Sep 3, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Headline News about Windtree Therapeutics Inc
< Previous
1
2
3
4
5
6
7
Next >
Istaroxime Update: Start Of Patient Dosing In Early Cardiogenic Shock SEISMiC Extension Study In Preparation For Phase 3 Readiness, Topline Data Expected mid-2024
December 18, 2023
Windtree Therapeutics, Inc. (NASDAQ: WINT) has recently enrolled the first subject in its phase 2 SEISMiC Extension Study to evaluate istaroxime in the treatment of early cardiogenic shock.
Via
Benzinga
Why Immunic Shares Are Trading Higher By Around 13%; Here Are 20 Stocks Moving Premarket
October 10, 2023
Gainers SuperCom Ltd. (NASDAQ: SPCB) shares rose 78.4% to $0.6425 in pre-market trading, after falling 13% on Monday.
Via
Benzinga
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Tuesday
October 10, 2023
It's time to dive into the biggest pre-market stock movers with all the most recent news moving shares on Tuesday morning!
Via
InvestorPlace
Why Windtree Therapeutics Stock Is Tumbling Today
April 20, 2023
Windtree Therapeutics Inc (NASDAQ: WINT) shares are plunging in early trading Thursday after the company announced the pricing of an upsized publ
Via
Benzinga
Why ParaZero Technologies Shares Are Trading Higher By Over 100%? Here Are Other Stocks Moving In Monday's Mid-Day Session
October 09, 2023
Gainers ParaZero Technologies Ltd. (NASDAQ: PRZO) shares jumped 106% to $2.3901 after the company announced an Australian regulator approved first commercial drone flights in populated areas and near...
Via
Benzinga
Windtree Therapeutics (NASDAQ: WINT) Is Developing A Multi-Asset Franchise Of Its Novel SERCA2a Activators In A Multi-Billion Dollar Market
August 15, 2023
Windtree Therapeutics, Inc. (NASDAQ: WINT) is a biotechnology company developing treatments for severe cardiovascular disorders.
Via
Benzinga
How Windtree Therapeutics (NASDAQ: WINT) Is Developing A Multi-Asset Franchise Of Its Novel SERCA2a Activators
August 15, 2023
Windtree Therapeutics, Inc. (NASDAQ: WINT) is a biotechnology company developing treatments for severe cardiovascular disorders.
Via
Benzinga
Stocks That Hit 52-Week Lows On Thursday
September 21, 2023
During the session on Thursday, 461 stocks hit new 52-week lows.
Via
Benzinga
Windtree Therapeutics' (NASDAQ: WINT) Upcoming Istaroxime Development Milestones And Next Generation Drug Candidates Could Produce New Fast Follow-On Line Of Drugs For Heart Failure
July 24, 2023
Windtree Therapeutics Inc. (NASDAQ: WINT) is looking to revolutionize acute care treatment for patients with serious conditions like acute heart failure (AHF) and cardiogenic shock (CS).
Via
Benzinga
The Acute Hospital Care Market Is Worth Over $3 Trillion, And Windtree Therapeutics Brings A First-In-Class Drug To An Active Segment Of This Market
July 17, 2023
The global acute hospital care market was worth $3.2 trillion in 2022 and is expected to grow at a compound annual growth rate (CAGR) of 5.62% from 2023 to 2030.
Via
Benzinga
Windtree Therapeutics – This Biotech Is Developing Drugs For Patients In Crisis
July 14, 2023
Craig Fraser, CEO of Windtree Therapeutics, Inc. (NASDAQ: WINT), was recently interviewed by Benzinga. Windtree is advancing late-stage interventions for cardiovascular disorders to treat patients in...
Via
Benzinga
Medical Management Of Deadly Urgent Cardiogenic Shock Largely Remains A Challenge – Windtree Therapeutics (NASDAQ: WINT) Is Helping Change That
July 12, 2023
Windtree Therapeutics, Inc. (NASDAQ: WINT), a biotechnology company treating late-stage acute cardiovascular disorders, is advancing its first-in-class drug for serious heart conditions.
Via
Benzinga
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Tuesday
May 30, 2023
It's time for a look at the biggest pre-market stock movers on Tuesday morning with all the details traders need to know about!
Via
InvestorPlace
Stocks That Hit 52-Week Lows On Thursday
May 25, 2023
On Thursday, 221 companies hit new 52-week lows.
Via
Benzinga
Why Meta Platforms Shares Are Trading Higher By Over 11%; Here Are 20 Stocks Moving Premarket
April 27, 2023
Gainers
Via
Benzinga
Nasdaq Down 100 Points; American Express Earnings Miss Views
April 20, 2023
U.S. stocks traded lower toward the end of trading, with the Nasdaq Composite dropping around 100 points on Thursday. The Dow traded down 0.51% to 33,725.78 while the NASDAQ fell 0.84% to 12,055.39....
Via
Benzinga
Stocks That Hit 52-Week Lows On Wednesday
April 26, 2023
On Wednesday, 345 companies set new 52-week lows.
Via
Benzinga
12 Health Care Stocks Moving In Thursday's Intraday Session
April 20, 2023
Via
Benzinga
Stocks That Hit 52-Week Lows On Tuesday
April 25, 2023
Tuesday's session saw 286 companies set new 52-week lows.
Via
Benzinga
Stocks That Hit 52-Week Lows On Monday
April 24, 2023
On Monday, 147 stocks made new 52-week lows.
Via
Benzinga
Crude Oil Down 2%; AT&T Shares Plunge After Q1 Results
April 20, 2023
U.S. stocks traded lower midway through trading, with the Nasdaq Composite dropping around 50 points on Thursday. The Dow traded down 0.26% to 33,809.22 while the NASDAQ fell 0.43% to 12,104.71. The...
Via
Benzinga
Dow Tumbles 150 Points; Tesla Shares Drop After Q1 Results
April 20, 2023
U.S. stocks traded lower this morning, with the Dow Jones dropping over 150 points on Thursday. Following the market opening Thursday, the Dow traded down 0.50% to 33,727.89 while the NASDAQ fell 0.49%...
Via
Benzinga
Stocks That Hit 52-Week Lows On Friday
April 21, 2023
During Friday's session, 149 stocks hit new 52-week lows.
Via
Benzinga
Why Is Bed Bath & Beyond (BBBY) Stock Down 19% Today?
April 20, 2023
Bed Bath & Beyond (BBBY) stock is sliding lower on Thursday as the retailer's shares come off of a recent meme stock rally.
Via
InvestorPlace
Why Nevro Shares Are Trading Lower By Around 19%? Here Are Other Stocks Moving In Thursday's Mid-Day Session
April 20, 2023
Gainers Aditxt, Inc. (NASDAQ: ADTX) shares gained 68.6% to $1.45. Aditxt signed asset purchase agreement to acquire 50% ownership of Global Response Aid with rights to manufacture and market...
Via
Benzinga
Why Is Windtree Therapeutics (WINT) Stock Down 58% Today?
April 20, 2023
Windtree Therapeutics (WINT) stock is falling on Thursday after the company announced the departure of its Chairman of the Board.
Via
InvestorPlace
12 Health Care Stocks Moving In Thursday's Pre-Market Session
April 20, 2023
Via
Benzinga
Stocks That Hit 52-Week Lows On Thursday
April 20, 2023
During Thursday's session, 99 companies made new 52-week lows.
Via
Benzinga
Benzinga Pro's Top 5 Stocks To Watch For Thursday, April 20, 2023: GOOGL, XPEV, ANET, MGM, WINT
April 20, 2023
Alphabet (GOOGL) - The company will report quarterly results next week on Tuesday after market close. Alphabet will kick off (along with Microsoft (MSFT), also on Tuesday afternoon) big tech
Via
Benzinga
Why MIND Technology Shares Are Trading Higher By Around 15%; Here Are 20 Stocks Moving Premarket
April 20, 2023
Gainers
Via
Benzinga
< Previous
1
2
3
4
5
6
7
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.